Specializing in Production and Events.

We offer two types of test:

PCR
The Fulgent Coronavirus Disease (COVID-19) RT-PCR test is a reverse transcription polymerase chain reaction test to detect SARS-CoV-2, the virus that causes COVID-19.

Rapid
The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19.

PCR
This test has been authorized by the FDA under an Emergency Use Authorization (EUA). This means that while the laboratory performing this test has validation data to support offering this test, it has not been approved or cleared by the FDA. This test has only been authorized by the FDA for detection of nucleic acid from SARS-CoV-2 (i.e., the COVID-19 virus), and not for any other virus or pathogen. It is only authorized during the duration of the COVID-19 emergency declaration by federal regulators under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1)

Rapid

• This test has not been FDA cleared or approved;
• This test has been authorized by FDA under an EUA for use by authorized laboratories;
• This test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and,
• This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

The COVID-19 PCR Swab test uses a nasal swab inserted into the upper part of each nostril to obtain a sample.  The same goes for our rapid test

PCR
99.9% at >3 copies/uL

Specificity
99.9% at >3 copies/uL

Rapid
BD Veritor™ Plus System has a 98%-100% specificity, which means the false positive rate is less than 2% of all the tests performed.